DataMeds AI (MEDS) Research & Development (2025 - 2026)
DataMeds AI's (MEDS) quarterly Research & Development came in at $960000.0 in Q1 2026, up 1372.01% on a YoY basis from $65217.0 in Q1 2025, and up 7785.66% quarter-over-quarter from $12174.0 in Q4 2025.
Powered by 
Analysis
DataMeds AI (MEDS) Research & Development (2025 - 2026) Analysis & Trends
DataMeds AI (MEDS) has reported Research & Development for 2 consecutive years, with $960000.0 the latest figure, recorded in Q1 2026.
- For the quarter ending Q1 2026, Research & Development rose 1372.01% year-over-year to $960000.0; the trailing twelve-month figure through Mar 2026 stood at $2.1 million (changed N/A YoY), and the FY2025 full-year result was $1.2 million, changed N/A from the prior year.
- Research & Development advanced to $960000.0 in Q1 2026 per MEDS's latest filing, from $12174.0 in the prior quarter.
- Across five years, Research & Development topped out at $960000.0 in Q1 2026 and bottomed at $12174.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 105.79 Bn | 103.19 Bn | 3.69 Bn | - |
| 2 | Cencora | 63.13 Bn | 60.51 Bn | 3.61 Bn | - |
| 3 | Cardinal Health | 57.48 Bn | 52.78 Bn | 2.56 Bn | - |
| 4 | Henry Schein | 10.05 Bn | 10.80 Bn | 1.10 Bn | - |
| 5 | ZeroStack | 42.83 Mn | 41.14 Mn | 1.62 Mn | - |
| 6 | 111 | 30.11 Mn | 113.01 Mn | 18.18 Mn | -8.41 Mn |
| 7 | Ridgetech | 5.33 Mn | -12.68 Mn | - | - |
| 8 | Guardian Pharmacy Services | 5.16 Mn | -72.61 Mn | 80.04 Mn | - |
| 9 | MedWellAI | 2.27 Mn | 2.28 Mn | - | - |
| 10 | DataMeds AI | 2.20 Mn | 2.15 Mn | 170,221.00 | 960,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 960,000.00 |
| Dec 31, 2025 | 12,174.00 |
| Sep 30, 2025 | 803,747.00 |
| Jun 30, 2025 | 343,383.00 |
| Mar 31, 2025 | 65,217.00 |